Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Sun Jianna"'
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Objective: Whether locoregional therapy (LRT) should be performed in patients with de novo metastatic breast cancer (dnMBC) has been debated. Here we report the survival outcomes of LRT in patients with dnMBC, focusing on the association of surgical
Externí odkaz:
https://doaj.org/article/dfb33306912e4b2fb38934a50f7c167f
Publikováno v:
In European Journal of Surgical Oncology January 2024 50(1)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer Research. 83:P4-07
Background: Breast cancer remains the most frequent type of cancer in women, with de novo metastatic breast cancer (dnMBC) accounting for approximately 6-10% of patients. Advances in treatment of dnMBC have led to an increase in overall survival (OS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72ce7fed5e322bb02d7ba6aac3831ff7
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-01
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-01
Publikováno v:
In Process Biochemistry April 2017 55:77-84
Publikováno v:
Cancer Research. 82:P1-15
Background: A growing number of studies are claiming lipid-lowering medications (LLMs) primarily statins have anticancer properties to inhibit proliferation, activate apoptosis, and reduce metastasis, but the clinical evidence applied to breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4250083f08398833300f7f79af1fa3d5
https://doi.org/10.1158/1538-7445.sabcs21-p1-15-03
https://doi.org/10.1158/1538-7445.sabcs21-p1-15-03
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer Research. 80:P1-20
Background: Stage IV breast cancer was considered to be an incurable disease with a poor survival outcome. Among them, patients with de novo stage IV breast cancer (BC) account for approximately 25%. Systemic therapy has remained the cornerstone of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d026adf3e93d1fb99c598128ad01fefe
https://doi.org/10.1158/1538-7445.sabcs19-p1-20-19
https://doi.org/10.1158/1538-7445.sabcs19-p1-20-19
Publikováno v:
Journal of Clinical Oncology. 40:e13044-e13044
e13044 Background: Breast cancer remains the most frequent type of cancer in women, with de novo metastatic breast cancer (dnMBC) accounting for approximately 10% of patients. Advances in diagnosis and treatment of breast cancer have led to an increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc8e3fbef5d650ed777d9e9d326ebe13
https://doi.org/10.1200/jco.2022.40.16_suppl.e13044
https://doi.org/10.1200/jco.2022.40.16_suppl.e13044
Background: In an earlier analysis of this cohort study, local therapy based on surgical resection of the primary tumor might confer a survival benefit in women with de novo metastatic breast cancer (dnMBC). Here we report the survival outcomes of lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8452b6944c18fb627029a4a2900793ca
https://doi.org/10.21203/rs.3.rs-70080/v1
https://doi.org/10.21203/rs.3.rs-70080/v1
